Get the Stockscreener App
4.81
1.64%
-0.08
After Hours:
4.84
0.03
+0.62%
Monte Rosa Therapeutics Inc stock is traded at $4.81, with a volume of 309.33K.
It is down -1.64% in the last 24 hours and up +8.09% over the past month.
Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.
See More
Previous Close:
$4.89
Open:
$4.96
24h Volume:
309.33K
Relative Volume:
0.77
Market Cap:
$297.06M
Revenue:
-
Net Income/Loss:
$-130.41M
P/E Ratio:
-2.1473
EPS:
-2.24
Net Cash Flow:
$-67.76M
1W Performance:
-2.63%
1M Performance:
+8.09%
6M Performance:
-27.56%
1Y Performance:
-19.30%
1-Day Range:
$4.795
$4.975
1-Week Range:
$4.79
$4.975
52-Week Range:
$3.5001
$12.40
Monte Rosa Therapeutics Inc Stock (GLUE) Company Profile
Name
Monte Rosa Therapeutics Inc
Sector
Industry
Phone
617-949-2643
Address
321 HARRISON AVENUE, BOSTON
Compare GLUE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GLUE
Monte Rosa Therapeutics Inc
|
4.81 | 296.44M | 0 | -130.41M | -67.76M | -2.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Monte Rosa Therapeutics Inc Stock (GLUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-15-24 | Initiated | Wedbush | Outperform |
| Jan-03-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-13-22 | Initiated | UBS | Buy |
| Aug-15-22 | Initiated | Jefferies | Buy |
| Apr-28-22 | Initiated | Credit Suisse | Neutral |
| Feb-10-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-14-21 | Initiated | SVB Leerink | Mkt Perform |
View All
Monte Rosa Therapeutics Inc Stock (GLUE) Latest News
Earnings visualization tools for Monte Rosa Therapeutics Inc.Earnings Growth Report & Community Trade Idea Sharing - Newser
Has Monte Rosa Therapeutics Inc. found a price floor2025 Growth vs Value & Weekly Chart Analysis and Trade Guides - Newser
Chart based analysis of Monte Rosa Therapeutics Inc. trends2025 Trade Ideas & Verified Short-Term Plans - Newser
Historical volatility pattern of Monte Rosa Therapeutics Inc. visualizedJuly 2025 Volume & Community Consensus Stock Picks - Newser
Will Monte Rosa Therapeutics Inc. price bounce be sustainableJuly 2025 Momentum & Weekly Stock Performance Updates - Newser
Institutional scanner results for Monte Rosa Therapeutics Inc.Market Performance Report & Long-Term Capital Growth Strategies - Newser
Chart overlay techniques for tracking Monte Rosa Therapeutics Inc.July 2025 Final Week & Safe Entry Trade Signal Reports - Newser
How to manage a losing position in Monte Rosa Therapeutics Inc.Weekly Trend Report & Daily Profit Focused Stock Screening - Newser
Will Monte Rosa Therapeutics Inc. benefit from macro trendsM&A Rumor & Safe Entry Zone Identification - Newser
Technical analysis overview for Monte Rosa Therapeutics Inc. stock2025 Support & Resistance & Safe Entry Zone Tips - Newser
Detecting price anomalies in Monte Rosa Therapeutics Inc. with AIJuly 2025 Selloffs & Short-Term High Return Strategies - Newser
Parkwood LLC Purchases 385,000 Shares of Monte Rosa Therapeutics, Inc. $GLUE - MarketBeat
117,672 Shares in Monte Rosa Therapeutics, Inc. $GLUE Purchased by Nuveen LLC - MarketBeat
What’s the recovery path for long term holders of Monte Rosa Therapeutics Inc.Sell Signal & Safe Entry Point Identification - Newser
How to monitor Monte Rosa Therapeutics Inc. with trend dashboardsPortfolio Risk Report & Real-Time Volume Spike Alerts - Newser
What institutional flow reveals about Monte Rosa Therapeutics Inc.2025 Fundamental Recap & Fast Gain Swing Trade Alerts - Newser
how to monitor monte rosa therapeutics inc. with trend dashboardsJuly 2025 Price Swings & Reliable Price Breakout Signals - Newser
How institutional ownership impacts Monte Rosa Therapeutics Inc. stock2025 Institutional Moves & Weekly Watchlist for Hot Stocks - Newser
How to escape a deep drawdown in Monte Rosa Therapeutics Inc.2025 Analyst Calls & Safe Entry Point Alerts - Newser
What to expect from Monte Rosa Therapeutics Inc. in the next 30 daysJuly 2025 Spike Watch & Low Volatility Stock Recommendations - Newser
What’s next for Monte Rosa Therapeutics Inc. stock price2025 Top Gainers & Scalable Portfolio Growth Methods - Newser
Order flow analysis tools used on Monte Rosa Therapeutics Inc.July 2025 Levels & Smart Allocation Stock Tips - Newser
What Fibonacci levels say about Monte Rosa Therapeutics Inc. reboundJuly 2025 Gainers & Expert Approved Momentum Trade Ideas - Newser
Monte Rosa Therapeutics Inc. Breaks Below Key Support LevelEarnings Recap Summary & Risk Controlled Stock Alerts - beatles.ru
BVF Inc. IL Raises Stock Position in Monte Rosa Therapeutics, Inc. $GLUE - MarketBeat
How to recover losses in Monte Rosa Therapeutics Inc. stock2025 Trade Ideas & Fast Gain Swing Alerts - Newser
Will earnings trigger a reversal in Monte Rosa Therapeutics Inc.2025 Key Highlights & Community Verified Swing Trade Signals - Newser
Monte Rosa Therapeutics, Inc. $GLUE Stake Raised by American Century Companies Inc. - Defense World
AlphaQuest LLC Cuts Stake in Monte Rosa Therapeutics, Inc. $GLUE - MarketBeat
Will Monte Rosa Therapeutics Inc. announce a stock split2025 EndofYear Setup & Fast Gain Stock Trading Tips - خودرو بانک
Will breakout in Monte Rosa Therapeutics Inc. lead to full recoveryJuly 2025 Rallies & Technical Pattern Alert System - Newser
Is Monte Rosa Therapeutics Inc.’s growth already priced inTrade Exit Report & Low Risk High Win Rate Picks - خودرو بانک
What is the dividend yield of Monte Rosa Therapeutics Inc.Trend Reversal & Long-Term Capital Growth Ideas - خودرو بانک
What MACD and RSI say about Monte Rosa Therapeutics Inc.Watch List & High Accuracy Investment Entry Signals - Newser
Can Monte Rosa Therapeutics Inc. withstand a market correctionJuly 2025 Big Picture & Safe Capital Investment Plans - خودرو بانک
What momentum shifts mean for Monte Rosa Therapeutics Inc.July 2025 Breakouts & Long Hold Capital Preservation Plans - Newser
Is Monte Rosa Therapeutics Inc. vulnerable to short sellersJuly 2025 WrapUp & Expert-Curated Trade Recommendations - خودرو بانک
What are analysts’ price targets for Monte Rosa Therapeutics Inc.Weekly Loss Report & Technical Confirmation Alerts - خودرو بانک
Can Monte Rosa Therapeutics Inc. be the next market leaderJuly 2025 Final Week & Weekly Breakout Watchlists - خودرو بانک
Can Monte Rosa Therapeutics Inc. disrupt its industryInsider Selling & Free Growth Oriented Trading Recommendations - خودرو بانک
Is Monte Rosa Therapeutics Inc. stock showing strong momentum2025 Winners & Losers & Weekly Stock Performance Updates - خودرو بانک
When is the best time to exit Monte Rosa Therapeutics Inc.July 2025 Recap & Verified Chart Pattern Trade Signals - Newser
Monte Rosa Therapeutics Inc Stock (GLUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):